Literature DB >> 33965232

The Finnish Allergy Program 2008-2018: Society-wide proactive program for change of management to mitigate allergy burden.

Tari Haahtela1, Erkka Valovirta2, Kimmo Saarinen3, Juha Jantunen3, Irmeli Lindström4, Paula Kauppi5, Tiina Laatikainen6, Anna Pelkonen5, Alexander Salava5, Erja Tommila7, Jean Bousquet8, Tuula Vasankari7, Mika J Mäkelä5.   

Abstract

A 10-year national program to improve prevention and management of allergic diseases and asthma was implemented in Finland (population 5.5. million) in 2008-2018. The main aim was to reduce the long-term burden of these conditions. The strategy was changed from traditional avoidance to tolerance and resilience of the population. Health was endorsed instead of medicalization of mild symptoms. Disease severity was reevaluated, and disabling clinical manifestations were given high priority. For health care, 5 quantitative goals and 1 qualitative goal were set. For each of the goals, specific tasks, tools, and outcome evaluation were stipulated. During the program, 376 educational sessions gathered 24,000 health care participants. An information campaign targeted the lay public, and social media was used to contact people. In the 10 years of the program, the prevalence of allergic diseases and asthma leveled off. Asthma caused fewer symptoms and less disability, and 50% fewer hospital days. Food allergy diets in day care and schools decreased by half. Occupational allergies were reduced by 45%. In 2018, the direct and indirect costs of allergic diseases and asthma ranged from €1.5 billion to €1.8 billion, with the 2018 figures being 30% less than in the respective figures in 2007. The Finnish proactive and real-world intervention markedly reduced the public health burden of allergic disorders. The allergy paradigm was revisited to improve management with systematic education.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergen avoidance; allergy prevention; allergy program; asthma program; tolerance

Year:  2021        PMID: 33965232     DOI: 10.1016/j.jaci.2021.03.037

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  6 in total

1.  Persistent asthma hospitalisations and deaths require a national asthma prevention plan.

Authors:  Bianca Beghé; Leonardo Fabbri; Enrico Clini
Journal:  Intern Emerg Med       Date:  2022-05-17       Impact factor: 5.472

2.  Welcome back Kotter-Developing a National Allergy strategy for Australia.

Authors:  Sandra L Vale; Maria Said; Jill Smith; Preeti Joshi; Richard Ks Loh
Journal:  World Allergy Organ J       Date:  2022-10-13       Impact factor: 5.516

3.  Planet earth is knocking on the doctor's door.

Authors:  Tari Haahtela; Josep M Anto; Jean Bousquet
Journal:  Porto Biomed J       Date:  2022-02-08

4.  Are there differences in the treatment information received to support guided self-management between asthma and allergy patients?: A community pharmacy survey in Finland.

Authors:  Juha Markus Heikkilä; Paula Bergman; Juha Jantunen; Johanna Salimäki; Paula Kauppi; Marika Pohjanoksa-Mäntylä
Journal:  Explor Res Clin Soc Pharm       Date:  2021-06-24

Review 5.  Dietary Factors Associated with Asthma Development: A Narrative Review and Summary of Current Guidelines and Recommendations.

Authors:  Preyanit Takkinsatian; Dara Mairiang; Sasipa Sangkanjanavanich; Chirawat Chiewchalermsri; Athiwat Tripipitsiriwat; Mongkhon Sompornrattanaphan
Journal:  J Asthma Allergy       Date:  2022-08-24

Review 6.  Managing the allergy and asthma epidemic in 2020s-Lessons from the Finnish experience.

Authors:  Tari Haahtela; Juha Jantunen; Kimmo Saarinen; Erja Tommila; Erkka Valovirta; Tuula Vasankari; Mika J Mäkelä
Journal:  Allergy       Date:  2022-03-09       Impact factor: 14.710

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.